Mac A. Johnson

发表

Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970

P. Reaper, P. Charlton, J. Pollard, 2014, Oncotarget.

Castration triggers growth of previously static androgen‐independent lesions in the transgenic adenocarcinoma of the mouse prostate (TRAMP) model

P. Iversen, G. Sandusky, J. Graff, 2005, The Prostate.

Isolation and characterization of mouse probasin: An androgen‐regulated protein specifically expressed in the differentiated prostate

Inmaculada Hernández, N. Greenberg, Mac A. Johnson, 2000, The Prostate.

Regulated expression of Wnts and Frizzleds at specific stages of follicular development in the rodent ovary.

J. Richards, M. Hsieh, N. Greenberg, 2002, Endocrinology.

Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model.

N. Greenberg, W. Huss, Gary J. Smith, 2007, Neoplasia.

Evidence for a p53‐independent pathway for upregulation of SDI1/CIP1/WAF1/P21 RNA in human cells

J. R. Smith, D. Dimitrov, J. Barrett, 1994, Molecular carcinogenesis.

The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.

David C. Jones, J. Graff, B. Neubauer, 2003, Cancer research.

Island biogeography effects on microbial evolution may contribute to Crohn's disease.

R. Winquist, Mac A. Johnson, 2011, Biochemical pharmacology.

Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970

P. Reaper, P. Charlton, D. Newsome, 2014, Oncotarget.